EDNRA and neoplasm: Considering the effects of β-arr as both cytoplasmic and nuclear messengers in tumor invasion and metastasis as well as in chemoresistance, the translation from basic biology to clinical drug development might consider that disruption of the ETAR/β-arr interaction can impair EMT, invasion, metastasis and chemoresistance, suggesting a possible avenue for therapeutic intervention.